Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
RESEARCH TOOLSreports
Holding EVFM?
Track your performance easily
EVFM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.23
Previous Close$0.01
Volume546.48K
Average Volume (3M)842.76K
Market Cap
$1.00M
Enterprise Value$1.51M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$511.00K
Price to Earnings (P/E)―
Beta-0.02
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding100,328,686
10 Day Avg. Volume843,853
30 Day Avg. Volume842,759
Standard Deviation0.41
R-Squared0.00971
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)-0.01
Price to Sales (P/S)0.06
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.09
Enterprise Value/Gross Profit0.13
Enterprise Value/Ebitda-0.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evofem Biosciences News
PremiumCompany Announcements
Evofem Biosciences Reports Q3 2024 Financial Results
PremiumCompany Announcements
Evofem Biosciences Gains Support for Aditxt Merger
PremiumCompany Announcements
Evofem Biosciences Faces Merger and Credit Challenges
PremiumCompany Announcements
Evofem Biosciences Expands Global Reach and Secures Funding
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EVFM FAQ
What was Evofem Biosciences’s price range in the past 12 months?
Evofem Biosciences lowest stock price was <$0.01 and its highest was $0.23 in the past 12 months.
What is Evofem Biosciences’s market cap?
Currently, no data Available
When is Evofem Biosciences’s upcoming earnings report date?
Evofem Biosciences’s upcoming earnings report date is May 07, 2025 which is in 156 days.
How were Evofem Biosciences’s earnings last quarter?
Evofem Biosciences released its earnings results on Nov 14, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.
Is Evofem Biosciences overvalued?
According to Wall Street analysts Evofem Biosciences’s price is currently Overvalued.
Does Evofem Biosciences pay dividends?
Evofem Biosciences does not currently pay dividends.
What is Evofem Biosciences’s EPS estimate?
Evofem Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evofem Biosciences have?
Evofem Biosciences has 100,328,690 shares outstanding.
What happened to Evofem Biosciences’s price movement after its last earnings report?
Evofem Biosciences reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evofem Biosciences?
Among the largest hedge funds holding Evofem Biosciences’s share is Baker Bros Advisors LP. It holds Evofem Biosciences’s shares valued at N/A.
---
Evofem Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
79.72%
Trailing 12-Months
Company Description
Evofem Biosciences
Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.
---
EVFM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---